Literature DB >> 22492670

MicroRNA expression and activity in pediatric acute lymphoblastic leukemia (ALL).

Jaqueline C de Oliveira1, María Sol Brassesco, Carlos Alberto Scrideli, Luiz Gonzaga Tone, Aru Narendran.   

Abstract

Acute lymphoblastic leukemia (ALL) is the most common type of pediatric neoplasia. Highly heterogeneous, ALL includes several genetic subtypes with varying clinical outcome. Although, some features are well established as prognostic predictors, the details of the molecular mechanisms underlying different phenotypes are only beginning to emerge. Recently, microRNAs (miRNAs) have been shown to influence a range of physiological processes and, consequently, alterations in their expression and functions have been associated with the development of many cancers, including leukemia. This article aims to review the current state of knowledge of the role of miRNAs on the biology of childhood ALL, also including relevant findings from the adult leukemia literature.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22492670     DOI: 10.1002/pbc.24167

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  17 in total

1.  Expression of certain leukemia/lymphoma related microRNAs and its correlation with prognosis in childhood acute lymphoblastic leukemia.

Authors:  Karolina Nemes; Monika Csóka; Noémi Nagy; Ágnes Márk; Zsófia Váradi; Titanilla Dankó; Gábor Kovács; László Kopper; Anna Sebestyén
Journal:  Pathol Oncol Res       Date:  2014-11-12       Impact factor: 3.201

Review 2.  Putting the "mi" in omics: discovering miRNA biomarkers for pediatric precision care.

Authors:  Chengyin Li; Rhea E Sullivan; Dongxiao Zhu; Steven D Hicks
Journal:  Pediatr Res       Date:  2022-07-29       Impact factor: 3.953

3.  Effects of Reduced Mir-24 Expression on Plasma Methotrexate Levels, Therapy-Related Toxicities, and Patient Outcomes in Pediatric Acute Lymphoblastic Leukemia.

Authors:  Mohammad Ali Esmaili; Ahmad Kazemi; Farhad Zaker; Mohammad Faranoush; Mohammad Reza Rezvany
Journal:  Rep Biochem Mol Biol       Date:  2020-01

4.  miR-582 Suppresses the Proliferation of B-Cell Precursor Acute Lymphoblastic Leukemia (BCP-ALL) Cells and Protects Them From Natural Killer Cell-Mediated Cytotoxicity.

Authors:  Xinxin Li; Yufei Zhang; Fei He; Dan Gao; Bo Che; Xiuli Cao; Siyong Huang; Minhua Zheng; Hua Han
Journal:  Front Immunol       Date:  2022-04-20       Impact factor: 8.786

Review 5.  Involvement of MicroRNA in T-Cell Differentiation and Malignancy.

Authors:  Najmaldin Saki; Saeid Abroun; Masoud Soleimani; Saeideh Hajizamani; Mohammad Shahjahani; Richard E Kast; Yousef Mortazavi
Journal:  Int J Hematol Oncol Stem Cell Res       Date:  2015-01-01

Review 6.  Epigenetic modifications in pediatric acute lymphoblastic leukemia.

Authors:  Michael J Burke; Teena Bhatla
Journal:  Front Pediatr       Date:  2014-05-14       Impact factor: 3.418

Review 7.  MicroRNA expression and activity in T-cell acute lymphoblastic leukemia.

Authors:  Fang Ye
Journal:  Oncotarget       Date:  2017-12-20

8.  miR-125b predicts childhood acute lymphoblastic leukaemia poor response to BFM chemotherapy treatment.

Authors:  Despina Piatopoulou; Margaritis Avgeris; Antonios Marmarinos; Marieta Xagorari; Margarita Baka; Dimitrios Doganis; Lydia Kossiva; Andreas Scorilas; Dimitrios Gourgiotis
Journal:  Br J Cancer       Date:  2017-08-08       Impact factor: 7.640

9.  Expression of miR-652-3p and Effect on Apoptosis and Drug Sensitivity in Pediatric Acute Lymphoblastic Leukemia.

Authors:  Qian Jiang; Xiaojing Lu; Pengli Huang; Chao Gao; Xiaoxi Zhao; Tianyu Xing; Gang Li; Shilai Bao; Huyong Zheng
Journal:  Biomed Res Int       Date:  2018-06-05       Impact factor: 3.411

Review 10.  Genetics and epigenetics of pediatric leukemia in the era of precision medicine.

Authors:  Kristie N Ramos; Irma N Ramos; Yi Zeng; Kenneth S Ramos
Journal:  F1000Res       Date:  2018-07-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.